Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;39(6):2323-2341.
doi: 10.1007/s12325-022-02110-8. Epub 2022 Apr 30.

Improving Care in Eosinophil-Associated Diseases: A Charter

David J Jackson  1   2 , Praveen Akuthota  3 , Rebeca Andradas  4 , Albert J Bredenoord  5 , Amanda Cordell  6 , Sarah Gray  7 , Joyce Kullman  8 , Sameer K Mathur  9 , Ian Pavord  10 , Florence Roufosse  11 , Christian Rubio  12 , Irena Clisson Rusek  13 , Dagmar Simon  14 , Mary Jo Strobel  15 , Tonya Winders  16   17
Affiliations

Improving Care in Eosinophil-Associated Diseases: A Charter

David J Jackson et al. Adv Ther. 2022 Jun.

Abstract

Eosinophil-associated diseases (EADs) are a range of heterogeneous conditions in which eosinophils are believed to play a critical pathological role. EADs include common illnesses such as eosinophilic asthma and chronic rhinosinusitis and rare conditions such as hypereosinophilic syndromes (HES) and eosinophilic gastrointestinal disorders (EGIDs). EADs are associated with substantial burdens for the patient, including chronic, debilitating symptoms, increased financial burden, decreased health-related quality of life, and the need for repeated visits to multiple different healthcare professionals (HCPs), emergency departments, and/or hospitals. Poor EAD recognition by HCPs often contributes to delayed diagnoses, which further delays patient access to appropriate care and effective treatments, contributing to poor health outcomes. The objective of this charter is to outline key patient rights and expectations with respect to the management of their condition(s) and to set forth an ambitious action plan to improve health outcomes for patients with EADs: (1) people with EADs, their caretakers, HCPs, and the public must have greater awareness and education about EADs; (2) people with EADs must receive a timely, accurate diagnosis; (3) all people with EADs must have access to an appropriate multidisciplinary team, when necessary; and (4) people with EADs must have access to safe and effective treatment options without unnecessary regulatory delays. The principles described in this charter demonstrate the core elements of quality care that people with EADs must receive, and they represent clear steps by which to reduce patient and caregiver burden and improve patient outcomes. We urge HCPs, healthcare systems, and policymakers worldwide to swiftly adopt these principles to ensure patients with EADs have an accurate diagnosis in a timely manner and access to high-level care and treatment in an appropriate setting.

Keywords: Eosinophil-associated diseases; Eosinophilic immune dysfunction (EID); Healthcare professional (HCP) education; Multidisciplinary teams (MDTs); Patient education; Patient rights; Timely diagnosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sastre B, Rodrigo-Munoz JM, Garcia-Sanchez DA, Canas JA, Del Pozo V. Eosinophils: old players in a new game. J Investig Allergol Clin Immunol. 2018;28(5):289–304. doi: 10.18176/jiaci.0295. - DOI - PubMed
    1. Cogan E, Roufosse F. Clinical management of the hypereosinophilic syndromes. Expert Rev Hematol. 2012;5(3):275–289. doi: 10.1586/ehm.12.14. - DOI - PubMed
    1. Simon D, Simon H-U. Eosinophils and skin diseases. In: Lee J, Rosenberg H, editors. Eosinophils in health and disease. 1. London: Academic Press; 2012. pp. 442–447.
    1. Gonsalves N. Eosinophilic gastrointestinal disorders. Clin Rev Allergy Immunol. 2019;57(2):272–285. doi: 10.1007/s12016-019-08732-1. - DOI - PubMed
    1. Klion AD, Ackerman SJ, Bochner BS. Contributions of eosinophils to human health and disease. Annu Rev Pathol. 2020;15:179–209. doi: 10.1146/annurev-pathmechdis-012419-032756. - DOI - PMC - PubMed

Publication types